Select language:  
1800 620 420
Close menu

Translational Research Program Grant recipients

The Leukaemia Foundation has joined forces with America’s The Leukemia & Lymphoma Society (LLS) and the Snowdome Foundation to fund blood cancer research projects with Australian researchers through the LLS Translational Research Program (TRP). The TRP is an LLS initiative that aims to fund new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.


A/Prof Jane Oliaro

Making CAR-T cell therapy more effective for aggressive lymphoma and multiple myeloma

Jane Oliaro

Professor Richard Lock

Improving outcomes for children with aggressive T-cell acute lymphoblastic leukemia

Professor Richard Lock


Dr. Lev Kats

Transforming discovery into difference, Dr. Lev Kats has multiple myeloma in his sights.


Professor John Pimanda

Optimising azacitidine (AZA) responsiveness in MDS, CMML and AML

Prof. John Pimanda (UNSW)

Professor Ravinda Majeti and Assoc. Professor Daniel Thomas

Personalized Metabolic Targeting of Epigenetic AML Mutations

Ravindra Majeti and Dan Thomas


Professor Ricky Johnstone

Targeting deregulated epigenetic mechanisms in B-cell lymphomas

Ricky Johnstone

Professor Stephen Nutt

Therapeutic targeting of IRF4 to treat multiple myeloma

Dr Stephen Nutt

Dr Ashwin Unnikrishnan

Beyond Azacitidine: Investigating new therapeutic strategies for the treatment of MDS

Ashwin Unnikrishnan

Dr Charles Mullighan

Improving therapy for CRLF2-rearranged Ph-like acute lymphoblastic leukemia

Charles Mullighan

Leukaemia and lymphoma society logo

Snowdome logo